FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Read more
Sandoz and Pear Therapeutics to develop and commercialize prescription digital therapeutics Read more
Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes Read more
Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria Read more
ProBioGen Signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project Read more
Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials Read more